RESUMO
Introduction Atresia of the external auditory canal affects 1 in every 10 thousand to 20 thousand live births, with a much higher prevalence in Latin America, at 5 to 21 out of every 10 thousand newborns. The treatment involves esthetic and functional aspects. Regarding the functional treatment, there are surgical and nonsurgical alternatives like spectacle frames and rigid and softband systems. Active transcutaneous bone conduction implants (BCIs) achieve good sound transmission and directly stimulate the bone. Objective To assess the audiological performance and subjective satisfaction of children implanted with an active transcutaneous BCI for more than one year and to compare the outcomes with a nonsurgical adhesive bone conduction device (aBCD) in the same users. Methods The present is a prospective, multicentric study. The audiological performance was evaluated at 1, 6, and 12 months postactivation, and after a 1-month trial with the nonsurgical device. Results Ten patients completed all tests. The 4-frequency pure-tone average (4PTA) in the unaided condition was of 65 dB HL, which improved significantly to 20 dB HL after using the BCI for 12 months. The speech recognition in quiet in the unaided condition was of 33% on average, which improved significantly, to 99% with the BCI, and to 91% with the aBCD. Conclusion The aBCD demonstrated sufficient hearing improvement and subjective satisfaction; thus, it is a good solution for hearing rehabilitation if surgery is not desired or not possible. If surgery is an option, the BCI is the superior device in terms of hearing outcomes, particularly background noise and subjective satisfaction.
RESUMO
Abstract Introduction Atresia of the external auditory canal affects 1 in every 10 thousand to 20 thousand live births, with a much higher prevalence in Latin America, at 5 to 21 out of every 10 thousand newborns. The treatment involves esthetic and functional aspects. Regarding the functional treatment, there are surgical and nonsurgical alternatives like spectacle frames and rigid and softband systems. Active transcutaneous bone conduction implants (BCIs) achieve good sound transmission and directly stimulate the bone. Objective To assess the audiological performance and subjective satisfaction of children implanted with an active transcutaneous BCI for more than one year and to compare the outcomes with a nonsurgical adhesive bone conduction device (aBCD) in the same users. Methods The present is a prospective, multicentric study. The audiological performance was evaluated at 1, 6, and 12 months postactivation, and after a 1-month trial with the nonsurgical device. Results Ten patients completed all tests. The 4-frequency pure-tone average (4PTA) in the unaided condition was of 65 dB HL, which improved significantly to 20 dB HL after using the BCI for 12 months. The speech recognition in quiet in the unaided condition was of 33% on average, which improved significantly, to 99% with the BCI, and to 91% with the aBCD. Conclusion The aBCD demonstrated sufficient hearing improvement and subjective satisfaction; thus, it is a good solution for hearing rehabilitation if surgery is not desired or not possible. If surgery is an option, the BCI is the superior device in terms of hearing outcomes, particularly background noise and subjective satisfaction.
RESUMO
Objetive: To linguistically adapt and validate the Spanish version of the PEACH rating scale and identify the variables associated.Design: A transversal study of parents/guardians of infants and children with either normal hearing or hearing impairment.Study sample: The protocol included translation into Spanish and adapted linguistically. Regression models were constructed using logistic regression, obtaining the respective areas under the ROC curve. Validity was studied through an exploratory factor analyses and reliability analysis was carried out using Cronbach's Alpha.Results: The PEACH rating scale was carried out on 297 parents. There was a high degree of reliability for both children with hearing impairment (Cronbach's Alpha: 0.93) and for those with normal hearing (Cronbach's Alpha: 0.82). The exploratory factor analysis showed the existence of one factor (unidimensional). In relation to the variables associated with the global scores of the scale, the type of hearing loss and laterality impact on the score. The area under the ROC curve was 0.89, showing elevated sensitivity and specificity.Conclusions: The adapted version can be used to evaluate the effectiveness of amplification for infants and children with hearing impairment in Spanish-speaking children. The PEACH rating scale to Spanish has validity indicators similar to the original.
Assuntos
Correção de Deficiência Auditiva/psicologia , Avaliação da Deficiência , Perda Auditiva/reabilitação , Inquéritos e Questionários/normas , Adolescente , Criança , Pré-Escolar , Análise Fatorial , Feminino , Perda Auditiva/psicologia , Humanos , Idioma , Modelos Logísticos , Masculino , Pais , Psicometria , Curva ROC , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Espanha , TraduçõesRESUMO
OBJECTIVE: To describe, in terms of functional gain and word recognition, the audiological results of patients under 18 years of age implanted with the active bone conduction implant, Bonebridge™. DESIGN: Retrospective case studies conducted by reviewing the medical records of patients receiving implants between 2014 and 2016 in the public health sector in Chile. STUDY SAMPLE: All patients implanted with the Bonebridge were included (N = 15). Individuals who had bilateral conductive hearing loss, secondary to external ear malformations, were considered as candidates. RESULTS: The average hearing threshold one month after switch on was 25.2 dB (95%CI 23.5-26.9). Hearing thresholds between 0.5 and 4 kHz were better when compared with bone conduction hearing aids. Best performance was observed at 4 kHz, where improvements to hearing were observed throughout the adaptation process. There was evidence of a significant increase in the recognition of monosyllables. CONCLUSIONS: The Bonebridge implant showed improvements to hearing thresholds and word recognition in paediatric patients with congenital conductive hearing loss.